在一种伴有显性中枢性眩晕的非典型 SCA13 中,电压依赖性 Kv3.3 通道中存在一种新型 KCNC3 基因变异。

IF 4.2 3区 医学 Q2 NEUROSCIENCES
Frontiers in Cellular Neuroscience Pub Date : 2024-10-02 eCollection Date: 2024-01-01 DOI:10.3389/fncel.2024.1441257
Felix P Bernhard, Sven Schütte, Moritz Heidenblut, Moritz Oehme, Susanne Rinné, Niels Decher
{"title":"在一种伴有显性中枢性眩晕的非典型 SCA13 中,电压依赖性 Kv3.3 通道中存在一种新型 KCNC3 基因变异。","authors":"Felix P Bernhard, Sven Schütte, Moritz Heidenblut, Moritz Oehme, Susanne Rinné, Niels Decher","doi":"10.3389/fncel.2024.1441257","DOIUrl":null,"url":null,"abstract":"<p><p>Potassium channel mutations play an important role in neurological diseases, such as spinocerebellar ataxia (SCA). SCA is a heterogeneous autosomal-dominant neurodegenerative disorder with multiple sub-entities, such as SCA13, which is characterized by mutations in the voltage-gated potassium channel Kv3.3 (<i>KCNC3</i>). In this study, we present a rare and atypical case of SCA13 with a predominant episodic central rotational vertigo, while the patient suffered only from mild progressive cerebellar symptoms, such as dysarthria, ataxia of gait and stand, and recently a cognitive impairment. In this patient, we identified a heterozygous variant in <i>KCNC3</i> (c.2023G > A, p.Glu675Lys) by next-generation sequencing. This Kv3.3<sup>E675K</sup> variant was studied using voltage-clamp recordings in <i>Xenopus</i> oocytes. While typical SCA13 variants are dominant-negative, show shifts in the voltage-dependence of activation or an altered TBK1 regulation, the Kv3.3<sup>E675K</sup> variant caused only a reduction in current amplitude and a more pronounced cumulative inactivation. Thus, the differences to phenotypes observed in patients with classical SCA13 mutations may be related to the mechanism of the observed Kv3.3 loss-of-function. Treatment of our patient with riluzole, a drug that is known to also activate potassium channels, turned out to be partly beneficial. Strikingly, we found that the Kv3.3 and Kv3.3<sup>E675K</sup> inactivation and the frequency-dependent cumulative inactivation was antagonized by increased extracellular potassium levels. Thus, and most importantly, carefully elevated plasma potassium levels in the physiological range, or novel drugs attenuating Kv3.3 inactivation might provide novel therapeutic approaches to rescue potassium currents of SCA13 variants <i>per se</i>. In addition, our findings broaden the phenotypic spectrum of Kv3.3 variants, expanding it to atypical phenotypes of Kv3.3-associated neurological disorders.</p>","PeriodicalId":12432,"journal":{"name":"Frontiers in Cellular Neuroscience","volume":"18 ","pages":"1441257"},"PeriodicalIF":4.2000,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480015/pdf/","citationCount":"0","resultStr":"{\"title\":\"A novel <i>KCNC3</i> gene variant in the voltage-dependent Kv3.3 channel in an atypical form of SCA13 with dominant central vertigo.\",\"authors\":\"Felix P Bernhard, Sven Schütte, Moritz Heidenblut, Moritz Oehme, Susanne Rinné, Niels Decher\",\"doi\":\"10.3389/fncel.2024.1441257\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Potassium channel mutations play an important role in neurological diseases, such as spinocerebellar ataxia (SCA). SCA is a heterogeneous autosomal-dominant neurodegenerative disorder with multiple sub-entities, such as SCA13, which is characterized by mutations in the voltage-gated potassium channel Kv3.3 (<i>KCNC3</i>). In this study, we present a rare and atypical case of SCA13 with a predominant episodic central rotational vertigo, while the patient suffered only from mild progressive cerebellar symptoms, such as dysarthria, ataxia of gait and stand, and recently a cognitive impairment. In this patient, we identified a heterozygous variant in <i>KCNC3</i> (c.2023G > A, p.Glu675Lys) by next-generation sequencing. This Kv3.3<sup>E675K</sup> variant was studied using voltage-clamp recordings in <i>Xenopus</i> oocytes. While typical SCA13 variants are dominant-negative, show shifts in the voltage-dependence of activation or an altered TBK1 regulation, the Kv3.3<sup>E675K</sup> variant caused only a reduction in current amplitude and a more pronounced cumulative inactivation. Thus, the differences to phenotypes observed in patients with classical SCA13 mutations may be related to the mechanism of the observed Kv3.3 loss-of-function. Treatment of our patient with riluzole, a drug that is known to also activate potassium channels, turned out to be partly beneficial. Strikingly, we found that the Kv3.3 and Kv3.3<sup>E675K</sup> inactivation and the frequency-dependent cumulative inactivation was antagonized by increased extracellular potassium levels. Thus, and most importantly, carefully elevated plasma potassium levels in the physiological range, or novel drugs attenuating Kv3.3 inactivation might provide novel therapeutic approaches to rescue potassium currents of SCA13 variants <i>per se</i>. In addition, our findings broaden the phenotypic spectrum of Kv3.3 variants, expanding it to atypical phenotypes of Kv3.3-associated neurological disorders.</p>\",\"PeriodicalId\":12432,\"journal\":{\"name\":\"Frontiers in Cellular Neuroscience\",\"volume\":\"18 \",\"pages\":\"1441257\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480015/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Cellular Neuroscience\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fncel.2024.1441257\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cellular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fncel.2024.1441257","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

钾通道突变在脊髓小脑共济失调(SCA)等神经系统疾病中起着重要作用。SCA是一种异质性常染色体显性神经退行性疾病,有多个亚型,如SCA13,其特点是电压门控钾通道Kv3.3(KCNC3)发生突变。在本研究中,我们发现了一例罕见的非典型 SCA13 病例,患者以发作性中枢旋转性眩晕为主,仅伴有轻度进行性小脑症状,如构音障碍、步态和站立共济失调,最近还出现了认知障碍。在这名患者身上,我们通过新一代测序鉴定出了一个 KCNC3 杂合变异体(c.2023G > A, p.Glu675Lys)。我们在章鱼卵母细胞中使用电压钳记录法研究了这种 Kv3.3E675K 变异。典型的 SCA13 变体是显性阴性的,表现出激活的电压依赖性变化或 TBK1 调节的改变,而 Kv3.3E675K 变体只导致电流振幅的降低和更明显的累积失活。因此,在经典 SCA13 突变患者身上观察到的表型差异可能与观察到的 Kv3.3 功能缺失的机制有关。利鲁唑是一种已知也能激活钾离子通道的药物,使用利鲁唑治疗我们的患者部分结果是有益的。令人震惊的是,我们发现 Kv3.3 和 Kv3.3E675K 失活以及频率依赖性累积失活被细胞外钾水平的增加所拮抗。因此,最重要的是,在生理范围内仔细提高血浆钾水平,或使用新型药物减弱 Kv3.3 失活,可能会为挽救 SCA13 变体本身的钾电流提供新的治疗方法。此外,我们的发现拓宽了 Kv3.3 变异的表型谱,将其扩展到 Kv3.3 相关神经系统疾病的非典型表型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A novel KCNC3 gene variant in the voltage-dependent Kv3.3 channel in an atypical form of SCA13 with dominant central vertigo.

Potassium channel mutations play an important role in neurological diseases, such as spinocerebellar ataxia (SCA). SCA is a heterogeneous autosomal-dominant neurodegenerative disorder with multiple sub-entities, such as SCA13, which is characterized by mutations in the voltage-gated potassium channel Kv3.3 (KCNC3). In this study, we present a rare and atypical case of SCA13 with a predominant episodic central rotational vertigo, while the patient suffered only from mild progressive cerebellar symptoms, such as dysarthria, ataxia of gait and stand, and recently a cognitive impairment. In this patient, we identified a heterozygous variant in KCNC3 (c.2023G > A, p.Glu675Lys) by next-generation sequencing. This Kv3.3E675K variant was studied using voltage-clamp recordings in Xenopus oocytes. While typical SCA13 variants are dominant-negative, show shifts in the voltage-dependence of activation or an altered TBK1 regulation, the Kv3.3E675K variant caused only a reduction in current amplitude and a more pronounced cumulative inactivation. Thus, the differences to phenotypes observed in patients with classical SCA13 mutations may be related to the mechanism of the observed Kv3.3 loss-of-function. Treatment of our patient with riluzole, a drug that is known to also activate potassium channels, turned out to be partly beneficial. Strikingly, we found that the Kv3.3 and Kv3.3E675K inactivation and the frequency-dependent cumulative inactivation was antagonized by increased extracellular potassium levels. Thus, and most importantly, carefully elevated plasma potassium levels in the physiological range, or novel drugs attenuating Kv3.3 inactivation might provide novel therapeutic approaches to rescue potassium currents of SCA13 variants per se. In addition, our findings broaden the phenotypic spectrum of Kv3.3 variants, expanding it to atypical phenotypes of Kv3.3-associated neurological disorders.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.90
自引率
3.80%
发文量
627
审稿时长
6-12 weeks
期刊介绍: Frontiers in Cellular Neuroscience is a leading journal in its field, publishing rigorously peer-reviewed research that advances our understanding of the cellular mechanisms underlying cell function in the nervous system across all species. Specialty Chief Editors Egidio D‘Angelo at the University of Pavia and Christian Hansel at the University of Chicago are supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信